


Hofseth International AS, a partly owned company by Chairman Roger Hofseth and
primary insider in Hofseth BioCare ASA has today, Monday 18 January 2016,
entered into an agreement to purchase 322,777 shares in HBC owned directly or
indirectly by Øystein Omvik, in connection with Øystein Omvik's search for new
challenges and resigning his position as Chief Financial Officer as of 18
January 2016.

The shares is purchased at a price of NOK 3.25, corresponding to a total
compensation of NOK 1,049,025.25. After this transaction, Hofseth International
AS owns a total of 2,474,063 shares in HBC, which represents 2.24 % of the total
outstanding shares. Øystein Omvik will after the transaction hold no shares
directly or indirectly in HBC.

For more information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Mobile: +47 936 32 966
Email: joo@hofsethbiocare.no

About Hofseth BioCare:
Hofseth BioCare is a Norwegian biotech company that offers high-value
ingredients and finished products for humans and pets. The company is founded on
the core values of sustainability, traceability and optimal utilization of
natural resources. Through an innovative hydrolysis technology, Hofseth BioCare
is able to preserve the quality of salmon oil, proteins and calcium, prepared of
fresh salmon off-cuts. Hofseth BioCare`s objective is to contribute to the
efficient use of marine resources and deliver quality products for ingredients
and finished consumer products in the nutrition market.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


[HUG#1979786] 
    